APA

Choi B. D., Yu X., Castano A. P., Darr H., Henderson D. B., Bouffard A. A., Larson R. C., Scarfò I., Bailey S. R., Gerhard G. M., Frigault M. J., Leick M. B., Schmidts A., Sagert J. G., Curry W. T., Carter B. S. & Maus M. V. (20200702). CRISPR-Cas9 disruption of PD-1 enhances activity of universal EGFRvIII CAR T cells in a preclinical model of human glioblastoma. : Journal for immunotherapy of cancer.

Chicago

Choi Bryan D, Yu Xiaoling, Castano Ana P, Darr Henia, Henderson Daniel B, Bouffard Amanda A, Larson Rebecca C, Scarfò Irene, Bailey Stefanie R, Gerhard Genevieve M, Frigault Matthew J, Leick Mark B, Schmidts Andrea, Sagert Jason G, Curry William T, Carter Bob S and Maus Marcela V. 20200702. CRISPR-Cas9 disruption of PD-1 enhances activity of universal EGFRvIII CAR T cells in a preclinical model of human glioblastoma. : Journal for immunotherapy of cancer.

Harvard

Choi B. D., Yu X., Castano A. P., Darr H., Henderson D. B., Bouffard A. A., Larson R. C., Scarfò I., Bailey S. R., Gerhard G. M., Frigault M. J., Leick M. B., Schmidts A., Sagert J. G., Curry W. T., Carter B. S. and Maus M. V. (20200702). CRISPR-Cas9 disruption of PD-1 enhances activity of universal EGFRvIII CAR T cells in a preclinical model of human glioblastoma. : Journal for immunotherapy of cancer.

MLA

Choi Bryan D, Yu Xiaoling, Castano Ana P, Darr Henia, Henderson Daniel B, Bouffard Amanda A, Larson Rebecca C, Scarfò Irene, Bailey Stefanie R, Gerhard Genevieve M, Frigault Matthew J, Leick Mark B, Schmidts Andrea, Sagert Jason G, Curry William T, Carter Bob S and Maus Marcela V. CRISPR-Cas9 disruption of PD-1 enhances activity of universal EGFRvIII CAR T cells in a preclinical model of human glioblastoma. : Journal for immunotherapy of cancer. 20200702.